Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 2, 2015Journal of HepatologyOpen Access

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B

View Full Paper
Ask AI
Bookmark
Share

Authors

SMStephan MenneGeorgetown UniversityDTDaniel B. TumasThe University of Texas MD Anderson Cancer CenterKLKatherine H. Liu

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Menne et al. (2015) studied this question.

synapsesocial.com/papers/6a7c6d76e7cf49620a26c3ebhttps://doi.org/10.1016/j.jhep.2014.12.026
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New Enzyme Immunoassays for the Serologic Detection of Woodchuck Hepatitis Virus Infection1993 · 58 citations
  2. 2TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFN-dependent pathway2011 · 108 citations
  3. 3Antiviral Activity of Clevudine [L–Fmau, (1–(2–Fluoro–5–Methyl–β, L–Arabinofuranosyl) Uracil)] Against Woodchuck Hepatitis Virus Replication and Gene Expression in Chronically Infected Woodchucks ( Marmota Monax )2001 · 129 citations
  4. 4Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA2014 · 903 citations
  5. 5Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis2013 · 68 citations